GR66630B - - Google Patents
Info
- Publication number
- GR66630B GR66630B GR61403A GR800161403A GR66630B GR 66630 B GR66630 B GR 66630B GR 61403 A GR61403 A GR 61403A GR 800161403 A GR800161403 A GR 800161403A GR 66630 B GR66630 B GR 66630B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH241579 | 1979-03-14 | ||
| CH17180 | 1980-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR66630B true GR66630B (el) | 1981-04-03 |
Family
ID=25683737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR61403A GR66630B (el) | 1979-03-14 | 1980-03-11 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0016371A1 (el) |
| AU (1) | AU5628380A (el) |
| DK (1) | DK108780A (el) |
| ES (1) | ES489493A0 (el) |
| FI (1) | FI800559A7 (el) |
| GR (1) | GR66630B (el) |
| IL (1) | IL59563A0 (el) |
| MC (1) | MC1317A1 (el) |
| NO (1) | NO800720L (el) |
| PT (1) | PT70949B (el) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| US7329670B1 (en) | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7351834B1 (en) | 1999-01-13 | 2008-04-01 | Bayer Pharmaceuticals Corporation | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| EP1140840B1 (en) | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7928239B2 (en) | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| EP2298311B1 (en) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7371763B2 (en) | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| WO2003068229A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
| ATE529406T1 (de) | 2002-02-11 | 2011-11-15 | Bayer Healthcare Llc | Aryl-harnstoffe als kinase inhibitoren |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
| EP1636585B2 (en) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| US7838524B2 (en) | 2004-04-30 | 2010-11-23 | Bayer Healthcare Llc | Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2448869A1 (de) * | 1973-10-19 | 1975-09-04 | Mcneilab Inc | 4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel |
| US3983135A (en) * | 1974-09-23 | 1976-09-28 | Mcneil Laboratories, Incorporated | 4-Oxo-2-imidazolidinylidene ureas |
| US4025517A (en) * | 1975-06-23 | 1977-05-24 | Mcneil Laboratories, Incorporated | 4-Oxo-2-hexahydropyrimidinylidene ureas |
-
1980
- 1980-02-26 FI FI800559A patent/FI800559A7/fi not_active Application Discontinuation
- 1980-03-05 EP EP80101097A patent/EP0016371A1/de not_active Withdrawn
- 1980-03-07 AU AU56283/80A patent/AU5628380A/en not_active Abandoned
- 1980-03-10 IL IL59563A patent/IL59563A0/xx unknown
- 1980-03-11 GR GR61403A patent/GR66630B/el unknown
- 1980-03-13 ES ES489493A patent/ES489493A0/es active Granted
- 1980-03-13 PT PT70949A patent/PT70949B/pt unknown
- 1980-03-13 NO NO800720A patent/NO800720L/no unknown
- 1980-03-13 DK DK108780A patent/DK108780A/da unknown
- 1980-03-14 MC MC801437A patent/MC1317A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0016371A1 (de) | 1980-10-01 |
| ES8103737A1 (es) | 1981-03-16 |
| FI800559A7 (fi) | 1981-01-01 |
| PT70949A (en) | 1980-04-01 |
| AU5628380A (en) | 1980-09-18 |
| DK108780A (da) | 1980-09-15 |
| NO800720L (no) | 1980-09-15 |
| MC1317A1 (fr) | 1981-03-10 |
| IL59563A0 (en) | 1980-06-30 |
| ES489493A0 (es) | 1981-03-16 |
| PT70949B (en) | 1981-06-24 |